businesspress24.com - Ingen Technologies, Inc. Announces Future Acquisition Plans
 

Ingen Technologies, Inc. Announces Future Acquisition Plans

ID: 1140466

Several Acquisition Planned Over the Next 12 Months; The First in Just Days

(firmenpresse) - RIVERSIDE, CA -- (Marketwire) -- 08/08/12 -- Ingen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with proprietary medical products for the growing $4B respiratory markets announced today that the company Chairman, Gary B. Tilden, has made the following statements regarding an upcoming acquisition.

"I am very pleased to announce that Ingen will be making several acquisitions over the next 12 months as a part of its Plan of Reorganization. The first acquisition should be announced in the next few days regarding a company with a proprietary, patented line of products for the healthcare industry. This is a monumental step forward for Ingen in building a solid foundation in which to grow upon. We believe that we have a strong medical product base that will continue to create longevity for our overall increasing revenue base. In addition, the potential market for our respiratory product line is approximately $200 million annually; and the new addition of this upcoming acquisition will open up new markets for Ingen in the healthcare and health & fitness industry."

FOR MORE UPDATED INFORMATION USE THE FOLLOWING LINK:

This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.



Contact:
Gary Tilden
951-688-7840





Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Cynapsus Therapeutics Awarded Grant from The Michael J. Fox Foundation for Clinical Examination of APL-130277, A Potential Rescue Therapy For Motor Fluctuations in Parkinson's Disease
Ergoresearch Announces Distribution Agreement With France's Leading Orthotics Firm
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 08.08.2012 - 06:30 Uhr
Sprache: Deutsch
News-ID 1140466
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

RIVERSIDE, CA


Phone:

Kategorie:

Alternative


Anmerkungen:


Diese Pressemitteilung wurde bisher 135 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ingen Technologies, Inc. Announces Future Acquisition Plans
"
steht unter der journalistisch-redaktionellen Verantwortung von

Ingen Technologies, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Ingen Technologies, Inc.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 82


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.